Overview
In this report we highlight opportunities for wearable DHTs to provide a patient-centric measure for use in clinical research. This information is driven by the patient-reported experiences in the Voice of the Patient Report associated with the FDA’s Patient-Focused Drug Development initiative.
We hope this information facilitates the consideration of digital measures as clinical development teams plan and execute their clinical trials.
This Hypertrophic Cardiomyopathy Digital Measure Report includes:
- Summary of the most significant symptoms reported by patients with Hypertrophic Cardiomyopathy and how these symptoms manifest in patients’ everyday lives
- Identified meaningful aspects of health based on the symptoms described
- Descriptions of candidate digital measures that can help assess the most significant symptoms expressed by patients with Hypertrophic Cardiomyopathy
- A link to the full Hypertrophic Cardiomyopathy Voice of the Patient Report
Related Resources: